Updated CMS Guidance on Organ Donation Processes and OPO Responsibilities
On March 11, 2026, the Centers for Medicare & Medicaid Services (CMS) released updated guidance on organ donation processes. This guidance, detailed in a Quality, Safety and Oversight memo and an amendment to the State Operations Manual, outlines the responsibilities of Organ Procurement Organizations (OPOs) and affiliated donor hospitals. It mandates that these entities provide comprehensive medical care regardless of donor status and allow families sufficient time to make organ donation decisions. This initiative, part of a larger effort by the U.S. Department of Health and Human Services, aims to enhance oversight, transparency, and accountability within the organ donation process.
In support of this initiative, CMS announced a proposed rule on January 28, 2026. This rule offers further guidance prior to the conclusion of the 2020 Final Rule's initial recertification cycle. While maintaining the three-tier system for evaluating OPOs based on donation and transplantation outcomes, it introduces continuous competition by assigning tier status at the Donation Service Area level. This proposal seeks to abolish previous limitations that restricted certification to specific OPOs and addresses criteria for certifying new organizations.
A 2023 CMS performance report, drawing on 2021 data, revealed that a substantial number of OPOs could face decertification based on their performance that year. The industry anticipates updated figures in 2026 to assess ongoing performance levels accurately. As the regulatory environment changes, CMS considers administrative modifications since the 2020 rule, informed by recent court rulings that have raised questions about various recertification criteria.
Legal challenges have emerged from several OPOs concerning the 2020 Final Rule, citing alleged statutory noncompliance and data reliability issues. Despite these legal disputes, CMS remains committed to the current framework, asserting that recent improvements in donation and transplant rates justify its approach.
The new guidance indicates heightened scrutiny in regulatory compliance and reporting discrepancies during inspections, noting that policy changes will apply retroactively. This development calls on OPOs, donor hospitals, and related parties to meticulously monitor and adapt to these regulatory modifications. Further clarification from authorities may be required to harmonize practices involving OPO participation in family interactions during the organ donation decision-making process.